Genitourinary Cancer

Featured

News
Association of Medicaid Expansion With the Presentation and Management of Genitourinary Cancers
Study findings suggest Medicaid expansion was associated with subsequent diagnosis and treatment outcomes for genitourinary malignant neoplasms, and may reduce socioeconomic…
Videos
Integrated Clinical and Claims Data Valuable for Clinical Decision Making in Genitourinary Cancer Care
Lincy Lal, PhD, discusses the utilization of integrated clinical and claims data to evaluate treatment patterns,…
Videos
First-Line Treatment Approaches for Metastatic Urothelial Cancer in the US
Petros Grivas, MD, PhD, discusses results from a study exploring decision-making processes regarding first-line…
Videos
Clinical Outcomes With Early vs Late Ra-223 for Patients With Metastatic CRPC
Richard Lee-Ying, MD, discusses clinical outcomes of patients with metastatic castrate resistant prostate cancer when…
Videos
Real-World Use of Cabozantinib Plus Direct Oral Anticoagulants in RCC
Akram Mesleh Shayeb, MD, discusses results from a real-world study evaluating cabozantinib in combination with direct…

News

Association of Medicaid Expansion With the Presentation and Management of Genitourinary Cancers
Health Care Spending for High-Resource Patients With Prostate Cancer
RT Added to ADT Cost-Effective vs ADT Alone for Metastatic Prostate Cancer
Comparative Effectiveness of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer

Guideline Updates

NCCN Updates Clinical Practice Guideline for Kidney Cancer

Interviews

Novel Liquid Biopsy for Prostate Cancer Projected to Save Millions for US Health Care System

Videos

Integrated Clinical and Claims Data Valuable for Clinical Decision Making in Genitourinary Cancer Care

Podcast

Prescribing Patterns in Metastatic Castrate-Sensitive Prostate Cancer

Conference Coverage

Nivolumab Plus Ipilimumab Cost-Effective for Intermediate or Poor Risk RCC
Back to Top